European VC Awards 2024: Celebrating Venture Capital Excellenceby Mark Eisenberg 16.02.2024The European VC has launched awards to celebrate the venture capital industry, recognizing exceptional individuals and firms. The event aims ...
Dyson V8 Cordless Vacuum: $121 Off Deal on Amazonby Lilu Anderson 16.02.2024Amazon has reduced the price of the Dyson V8 Cordless Vacuum by $121, making it an even more attractive option ...
China’s $457B Lifeline: Rescuing Property Sectorby Mark Eisenberg 16.02.2024Chinese banks have been matched with over 8,200 residential projects for development loans under the "whitelist" mechanism. This move aims ...
Amazon Prime Faces Lawsuit Over Deceptive Ads: Impact on Subscribersby Mark Eisenberg 16.02.2024Amazon is facing a lawsuit over allegations of deceiving Prime Video subscribers with advertisements. Plaintiff seeks class action status and ...
IAG Customers Brace for Price Surge Amid Rising Costsby Mark Eisenberg 16.02.2024IAG customers will face rising car and home insurance premiums as the company grapples with higher reinsurance expenses and natural ...
Genuine Parts Co: Surpasses $23B 2023 Salesby Mark Eisenberg 16.02.2024Genuine Parts Company reports $23 billion in sales for 2023, achieving three years of double-digit earnings growth. Integration, restructuring, and ...
Jeff Bezos Sells $6B in Amazon Shares: What’s Next?by Mark Eisenberg 16.02.2024Jeff Bezos sells $2.03 billion worth of Amazon shares, bringing his monthly sales to $6 billion, raising concerns about Amazon's ...
Meta vs. Apple: The Battle Over Ad Fees Escalatesby Lilu Anderson 16.02.2024Meta Platforms and Apple are locked in a battle over advertiser charges on iOS. Meta's guidelines to help advertisers avoid ...
Fox News Dominates Multiplatform Supremacyby Lilu Anderson 16.02.2024Fox News Digital remains the top news brand for the 35th consecutive month, leading in multiplatform views and minutes. Impressive ...
FTC Probe into Big Pharma Sparks Drug Price Surgeby Mark Eisenberg 16.02.2024Health-care companies are rallying amid expectations of higher drug prices and ongoing pharmaceutical shortages in the US. The FTC is ...